|
Market Closed -
Other stock markets
|
Pre-market 04:39:14 pm | |||
| 76.91 USD | +3.19% |
|
76.41 | -0.65% |
| 15/07 | Zoetis Inc. Launches Lenivia (Izenivetmab Injection) in Canada and the European Union | CI |
| 14/07 | Zoetis to Acquire Veterinary Teleradiology Services Platform VitalRADS | MT |
Business description: Zoetis Inc.

- companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%);
- livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%);
- other (0.9%).
Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%).
At the end of 2024, the group has 22 production sites worldwide.
The United States accounts for 54.8% of net sales.
Number of employees: 14,500
Sales by Activity: Zoetis Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
United States (U.S.) | 404.2Cr | 431.3Cr | 455.5Cr | 507.4Cr | 509.7Cr |
International | 365.2Cr | 368.1Cr | 391.1Cr | 410.2Cr | 425.4Cr |
Unallocated Contract Manufacturing & Human Health | 8.2Cr | 8.6Cr | 7.8Cr | 8Cr | 12Cr |
Geographical breakdown of sales: Zoetis Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
United States (U.S.) | 404.2Cr | 431.3Cr | 455.5Cr | 507.4Cr | 509.7Cr |
Other Emerging Markets | 78Cr | 76Cr | 78Cr | 86Cr | 91Cr |
Other Developed Markets | 47Cr | 47Cr | 51Cr | 56Cr | 64Cr |
Brazil | 31Cr | 33Cr | 39Cr | 41Cr | 39Cr |
Australia | 26Cr | 29Cr | 32Cr | 32Cr | 33Cr |
United Kingdom | 23Cr | 24Cr | 28Cr | 31Cr | 32Cr |
Canada | 23Cr | 24Cr | 26Cr | 28Cr | 29Cr |
Germany | 18Cr | 18Cr | 20Cr | 22Cr | 24Cr |
China | 36Cr | 38Cr | 32Cr | 27Cr | 23Cr |
France | 13Cr | 13Cr | 14Cr | 16Cr | 16Cr |
Mexico | 13Cr | 14Cr | 16Cr | 17Cr | 16Cr |
Japan | 19Cr | 17Cr | 16Cr | 15Cr | 15Cr |
Spain | 13Cr | 12Cr | 12Cr | 13Cr | 14Cr |
Chile | 14Cr | 14Cr | 14Cr | 12Cr | 14Cr |
Italy | 12Cr | 11Cr | 12Cr | 13Cr | 14Cr |
Unallocated | 8.2Cr | 8.6Cr | 7.8Cr | 8Cr | 12Cr |
Executive Committee: Zoetis Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Kristin Peck
CEO | Chief Executive Officer | 54 | 01/01/2020 |
Wetteny Joseph
DFI | Director of Finance/CFO | 54 | 01/06/2021 |
Kevin Esch
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/01/2026 |
Julie Fuller
COO | Chief Operating Officer | 53 | 01/08/2024 |
| Chief Tech/Sci/R&D Officer | - | 21/03/2024 |
Composition of the Board of Directors: Zoetis Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Frank D'Amelio
BRD | Director/Board Member | 68 | 01/07/2012 |
Gregory Norden
BRD | Director/Board Member | 68 | 01/01/2013 |
| Chairman | 73 | 26/06/2013 | |
Sanjay Khosla
BRD | Director/Board Member | 73 | 01/06/2013 |
Willie Reed
BRD | Director/Board Member | 71 | 04/03/2014 |
Paul Bisaro
BRD | Director/Board Member | 65 | 01/05/2015 |
Kristin Peck
BRD | Director/Board Member | 54 | 02/10/2019 |
| Director/Board Member | 64 | 08/12/2020 | |
| Director/Board Member | 57 | 25/07/2022 | |
Gavin Hattersley
BRD | Director/Board Member | 63 | 01/04/2024 |
Company details: Zoetis Inc.

Group companies: Zoetis Inc.
| Name | Category and Sector |
|---|---|
Zoetis Treasury Center BV | |
Zoetis Ceská republika sro
Zoetis Ceská republika sro BiotechnologyHealth Technology Researches, develops, manufactures and markets medicines and vaccines for animals |
Biotechnology
|
Zoetis Korea Ltd.
Zoetis Korea Ltd. Pharmaceuticals: MajorHealth Technology Manufactures veterinary medicinal preparations |
Pharmaceuticals: Major
|
Zoetis Philippines, Inc. | |
Pharmaq Vietnam Co. Ltd. |
Veterinary Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.19% | +2.44% | -49.25% | -55.33% | 3.22TCr | ||
| +1.61% | +5.40% | +78.84% | +119.17% | 1.3TCr | ||
| +4.18% | +4.85% | -15.35% | +2.49% | 373.73Cr | ||
| 0.00% | +1.87% | -8.03% | +31.12% | 312.93Cr | ||
| -1.56% | -1.31% | +38.80% | +26.00% | 193.9Cr | ||
| +1.84% | +8.54% | -23.50% | +26.15% | 178.7Cr | ||
| +2.31% | +6.61% | +13.03% | +136.76% | 140.03Cr | ||
| +0.92% | +7.24% | -23.50% | -11.04% | 110.2Cr | ||
| +1.84% | +10.48% | -15.41% | -43.87% | 100.1Cr | ||
| +0.41% | +2.82% | -8.86% | -17.70% | 97Cr | ||
| Average | +1.09% | +4.38% | -1.32% | +21.37% | 602.66Cr | |
| Weighted average by Cap. | +0.37% | +3.48% | -10.73% | +1.37% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZTS Stock
- Company Zoetis Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















